Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

Choosing a Journal: What Matters More Than Impact Factor?

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

Bimekizumab Gives Lasting Symptom Relief in PsA

In patients with psoriatic arthritis, long-term bimekizumab treatment shows sustained improvement in symptoms and disease impact, according to an analysis of data from two phase 3 trials.

MHRA Isotretinoin Rules Wasted 12,000 Hours, Analysis Finds

Isotretinoin rules imposed over psychiatric concerns cost the NHS up to £1.4 million in wasted clinical time, dermatologists calculate.

Dr. Bolu Ogunyemi Becomes New CMA President

Bolu Ogunyemi, MD, dermatologist from St. John’s, Newfoundland and Labrador, has become the Canadian Medical Association’s first Black president and is among its youngest.

Can Oral Icotrokinra Relieve High-Impact Site Psoriasis?

Icotrokinra yields high clearance and durable response rates at high-impact sites in patients with psoriasis, with no added adverse events compared with placebo, a 1-year assessment of a trial shows.

Pictogram Decision Aid Tool Improves HCQ Adherence in Lupus

A pictogram-based shared decision-making tool improves hydroxychloroquine adherence and reduces decisional conflicts in patients with SLE while requiring less time to deliver.

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Latest News

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

In patients with psoriatic arthritis, long-term bimekizumab treatment shows sustained improvement in symptoms and disease impact, according to an analysis of data from two phase 3 trials.

Isotretinoin rules imposed over psychiatric concerns cost the NHS up to £1.4 million in wasted clinical time, dermatologists calculate.

Bolu Ogunyemi, MD, dermatologist from St. John’s, Newfoundland and Labrador, has become the Canadian Medical Association’s first Black president and is among its youngest.

Icotrokinra yields high clearance and durable response rates at high-impact sites in patients with psoriasis, with no added adverse events compared with placebo, a 1-year assessment of a trial shows.

A pictogram-based shared decision-making tool improves hydroxychloroquine adherence and reduces decisional conflicts in patients with SLE while requiring less time to deliver.

News All Time

Mohs for Rare Skin Cancer Linked to Lower Recurrence vs WLE

Mohs micrographic surgery reduces positive margins and 5-year recurrence in patients with dermatofibrosarcoma protuberans, compared with wide local excision, study finds.

The Potential for Remission, Cure in Psoriasis

'With the IL-23 blockers, for the first time ever, we've … seen a disconnect between drug levels in the blood and the ability to stay in remission,' says Andrew Blauvelt, MD.

FDA Approves OTC Switch for Topical Acne Treatment

The product combining adapalene 0.1% and benzoyl peroxide 2.5% was approved as a prescription acne treatment in December 2008 for patients aged 12 years and older.

Genital Lesions Most Common Sign of CCD

Most patients with cutaneous Crohn’s disease present with genital lesions and show good response with biologic therapy, according to a study shows.

Botulinum Toxin for Frown Lines Moves Toward EU Approval

EMA advisers have backed a botulinum toxin for moderate to severe frown lines in adults, with reported onset of action as early as 8 hours and effects lasting 2-3 weeks.

Epidermolysis Bullosa: New Therapies Bring Hope, Healing

FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.

Expert Guidance on Stacking Systemic Therapies for Psoriasis

Advice on when and how to switch or stack treatments can help in cases of an incomplete or waning response.

Endocrine Disruptors: Could Exposure Affect Generations?

Clinicians are urged to consider cumulative endocrine disruptor exposure in patients with unexplained hormonal and metabolic symptoms.

EMA Backs First Drug for Severe Overgrowth Disorders

The conditional authorization covers adults and children aged 2 years and older with severe or life-threatening PIK3CA-related overgrowth disorders.

Many Patients Seeking Skin Cancer Screening Are Low Risk

Older age, lighter skin phototypes, and personal skin cancer history are linked to higher skin cancer detection rates during routine skin examinations, study shows.

Emerging Technology More Accurate Than FS in Mohs Study

Two-photon fluorescence microscopy has greater specificity, and noninferiority in sensitivity than frozen sections, suggesting a way to reduce taking unnecessary stages in Mohs surgery.

UK Approves First Gene Therapy Gel for Rare Skin Disorder

The MHRA has approved beremagene geperpavec gel for DEB wounds — the first topical gene therapy for the condition, usable from birth.

Consider This Burnout Survey When Considering Your Specialty

Burnout is a problem in every specialty, but there’s high variability.

Isotretinoin Plus Laser Safe, Effective for Rhinophyma

Carbon dioxide laser resurfacing plus isotretinoin is safe and effective for treating rhinophyma, new research suggests, despite past warnings about combining the modalities.

Mohs Surgery With Narrower Margins Safe for Some MIS Cases

The two factors associated with needing larger final margins were older patient age and larger average preoperative tumor diameters, according to a single-center review of 530 primary MIS cases.

CO2 Laser Excision for Severe HS: Small Study Shows Benefits

The use of CO2 laser to excise lesions in patients with severe hidradenitis was effective and well-tolerated in a small retrospective review.

Recommended News For You

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

Breast density changes over time are associated with an increased risk of cancer.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

How cancer misinformation exploits the way we think

Recommended Articles For You

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology 

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist  

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

2.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

3.

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

4.

Prostate cancer screening program beneficial in top decile of polygenic risk score

5.

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

1.

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights

2.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

3.

Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology

4.

The Future of Oncology: Innovations Every Doctor Should Know

5.

Exploring The Causes and Consequences of Low Transferrin Saturation

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot